Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (October 2025)
08:00am, Saturday, 04'th Oct 2025
Shares of Pfizer ( NYSE: PFE ) gained 10.02% over the past month after gaining 4.50% the month prior.
The Score: Pfizer, Tesla, Electronic Arts and More Stocks That Defined the Week
05:17pm, Friday, 03'rd Oct 2025
Here are some of the major companies whose stocks moved on the week's news
Pharmaceutical Stocks: Valuations And Pipelines Are Only Beginning To Be Appreciated
04:20pm, Friday, 03'rd Oct 2025
Drug stocks are poised to outperform in 2025, driven by conservative valuations and a research renaissance in key therapeutic areas. US healthcare spending growth and transformative GLP-1 therapies, e
Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?
11:01am, Friday, 03'rd Oct 2025
Pfizer surges 14% after landmark Trump deal slashing drug prices while boosting U.S. investments.
These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True?
04:20am, Friday, 03'rd Oct 2025
Did you know that if you have a reliable income stock that yields 6%, you would only need to invest about $16,700 in it to collect $1,000 in dividends over the course of a full year? The average stock
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
03:48am, Friday, 03'rd Oct 2025
Does the government shutdown have you feeling queasy about investing in stocks? It's understandable, but history says your portfolio's going to be just fine.
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?
03:15am, Friday, 03'rd Oct 2025
The biggest risks facing pharmaceutical companies in recent times haven't had to do with clinical trials or winning regulatory approval. Instead, investors have worried about President Donald Trump's
Down-to-the wire team negotiations capped a long dance between President Trump and CEO Albert Bourla.
Pfizer: The Long Suffering Is Finally Over (Rating Upgrade)
09:00am, Thursday, 02'nd Oct 2025
Pfizer Inc. has secured an MFN pricing deal with the White House, easing recent tariff and drug repricing concerns while affording a win for Trump. PFE's solid dividend yield of >6% provides a robust
3 Things You Need to Know if You Buy Pfizer Today
07:02am, Thursday, 02'nd Oct 2025
The big draw for most investors with Pfizer (PFE 6.77%) today is likely to be its lofty 7.2% dividend yield. That compares to 1.2% for the S&P 500 index and about 1.3% for the average pharmaceutical s
Heard on the Street: Pfizer's accord on price cuts with President Trump clears a cloud over the whole pharma industry
07:00am, Thursday, 02'nd Oct 2025
The company's accord with the president clears a cloud over the whole sector.
3 Mega Dividend Stocks With Yields as High as 13.4%
05:11am, Thursday, 02'nd Oct 2025
Dividend yields are historically low these days. The S&P 500 yields less than 1.2%, which is near its lowest level on record.
Government Shutdown, Government Shmutdown
07:46pm, Wednesday, 01'st Oct 2025
Market indexes were ultimately unbothered by this latest federal government shutdown today, to say nothing of the negative private-sector payroll report this morning.
Top 3 Dividend Achievers for October: High Yields, Growth Ahead
05:55pm, Wednesday, 01'st Oct 2025
These stocks are attractive investments due to their proven models, stable cash flow, and ability to sustain capital returns, which may also lead to share price increases and capital gains.
Why Pfizer Stock Trounced the Market Today
05:08pm, Wednesday, 01'st Oct 2025
Still basking in the glow of a likely advantageous deal it signed with the government the previous day, Pfizer's (PFE 6.77%) stock was extremely healthy on Hump Day. That positive sentiment was booste
